Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.

Nat Commun · 2023 · PMC9849267 · PMID 36653361

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

2d, e ) showed a trend towards reduced EpCAM+ tumor cell content, and a 2.5-fold reduction in EpCAM+MSI2+ cancer stem cells at midpoint (7–8 weeks) (Fig. 2b , Supplementary Fig. 2f ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.